Vyome Holdings HIND
NASDAQ HIND
$1.87 +0.03 (+1.63%)
As of: Oct 21, 2026 · 12:04 PM EDT

Vyome Holdings (HIND) Convertible Debt (2024)

Updated

Vyome Holdings (HIND) posted Convertible Debt of $3.59 million for Q4 2024, up 2.9% from the prior quarter.

Analysis

Vyome Holdings (HIND) Convertible Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn
10 Vyome Holdings 13.12 Mn -14.25 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.59 Mn
Sep 30, 2024 3.49 Mn
API Access

Vyome Holdings Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=HIND&period=max&api_key=YOUR_API_KEY